Research programme: tetrahydropyrrol derivatives - Guangdong Zhongsheng Pharmaceutical

Drug Profile

Research programme: tetrahydropyrrol derivatives - Guangdong Zhongsheng Pharmaceutical

Alternative Names: WXFL078

Latest Information Update: 29 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Guangdong Zhongsheng Pharmaceutical
  • Class Pyrrolidines
  • Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor delta agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Non-alcoholic steatohepatitis

Most Recent Events

  • 20 Oct 2017 Preclinical trials in Non-alcoholic steatohepatitis in China (PO)
  • 20 Oct 2017 Pharmacodynamics data from a preclinical study in Non-alcoholic steatohepatitis presented at the Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top